oxycodone has been researched along with buprenorphine in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.63) | 18.7374 |
1990's | 1 (1.41) | 18.2507 |
2000's | 10 (14.08) | 29.6817 |
2010's | 43 (60.56) | 24.3611 |
2020's | 13 (18.31) | 2.80 |
Authors | Studies |
---|---|
Laitinen, J; Nuutinen, L | 1 |
Foley, KM; Houde, RW; Inturrisi, CE; Moulin, DE; Nip, TJ; Reidenberg, B; Wallenstein, S; Weinberg, DS | 1 |
Hovorka, J; Korttila, K | 1 |
Sjövall, S | 1 |
Hästbacka, J; Tammisto, T; Tigerstedt, I; Turunen, M | 1 |
Lindena, G; Müller-Busch, HC; Tietze, K; Woskanjan, S | 1 |
Bug, C; Earnshaw, S; Greiner, W; Lehmann, K; Sabatowski, R | 1 |
Ahmad, R; Davies, AN; Hirani, E; Hume, SP; Lingford-Hughes, AR; Nataf, V; Nutt, DJ | 1 |
Cicero, TJ; Inciardi, JA; Munoz, A; Surratt, H | 1 |
Sabatowski, R | 1 |
Bailey, JE; Campagna, E; Dart, RC | 1 |
Hass, B; Hertel, N; Kotowa, W; Liedgens, H; Lungershausen, J; Poulsen Nautrup, B | 1 |
Bandieri, E; Chiarolanza, A; Luppi, M; Magrini, N; Marata, AM; Ripamonti, C | 1 |
Jenkins, AJ; Juhascik, MP; Poirier, JG | 1 |
Carter, LP; Haddox, JD; Henningfield, JE; Johnson, RE; Lindholm, A; McCormick, CG; Rosen, S; Seeger, V; Varughese, S; Waxman, D; Wissel, J | 1 |
Comer, SD; Jones, JD; Manubay, J; Sullivan, MA; Vosburg, SK | 1 |
Jarlbaek, L; Kehlet, H; Sjøgren, P | 1 |
Christophersen, AS; Johansen, U; Oiestad, AM; Oiestad, EL | 1 |
Hale, M; Landau, C; Munera, C; Ripa, S; Steiner, D | 1 |
Hendrickson, RG; McKeown, NJ | 1 |
Ferrara, MM | 1 |
Häkkinen, M; Launiainen, T; Ojanperä, I; Vuori, E | 1 |
Tenore, PL | 1 |
Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
Uddin, F | 1 |
Cohen, J; Comer, SD; Cooper, ZD; Fugon, L; Jones, JD; Manubay, JM; Mogali, S; Roux, P; Sullivan, MA; Vosburg, SK | 1 |
Comer, SD; Cooper, ZD; Jones, JD; Kowalczyk, WJ; Manubay, JM; Metz, VE; Peyser, D; Saccone, PA; Smith, ME; Sullivan, MA; Vosburg, SK | 1 |
Kuo, A; Meutermans, W; Smith, MT; Wyse, BD | 1 |
Ahmedzai, SH; Boland, JW; Foulds, GA; Pockley, AG | 1 |
Chen, LC; Knaggs, RD; Zin, CS | 1 |
Hernandez, DO; Koob, GF; Schlosburg, JE; Vendruscolo, LF; Wade, CL | 1 |
Lautermilch, NJ; Morgan, MM; Reid, RA; Stormann, TM | 1 |
Fredheim, OM | 1 |
Backman, E; Höjer, J; Jonsson, B; Salmonson, H | 1 |
Bernardy, K; Häuser, W; Maier, C | 1 |
Fang, WB; Liu, F; Moody, DE | 1 |
Duse, G; Ferrari, R; Visentin, M; Zanolin, ME | 1 |
Knothe, C; Lötsch, J; Walter, C | 1 |
Babalonis, S; Casselton, V; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
Bruno, R; Degenhardt, L; Demirkol, A; Lintzeris, N; Nielsen, S | 1 |
Gurwitz, JH; Hume, AL; Lapane, KL; Pimentel, CB; Tjia, J | 1 |
Freeto, SM; LeQue, JJ; Ohouo, PY; Rosano, TG; Wood, M | 1 |
Cirone, S; Edwards, C; Folk, D; Gordon, J; Kahan, M; Kanate, D; Kelly, L; Kirlew, M; Main, F; Mamakwa, S; Parsons, P; Rea, S | 1 |
Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ | 1 |
Leppert, W; Nosek, H; Nosek, K; Onichimowski, D; Wordliczek, J | 1 |
Bryniarski, K; Filipczak-Bryniarska, I; Kozlowski, M; Nazimek, K; Nowak, B; Wąsik, M | 1 |
de C Williams, AC; Donaldson, LJ; Mordecai, L; Reynolds, C | 1 |
Fang, WB; Fu, Y; Moody, DE | 1 |
Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M | 1 |
Brooke Lerner, E; Fumo, N; Peterson, BL; Schreiber, S | 1 |
Guevara, M; Hofilena, D; Mikel, C; West, R | 1 |
Eng, G; Wakeman, SE; Walley, AY | 1 |
Buckley, NA; Litchfield, M; Narayan, SW; Pearson, SA; Schaffer, AL; Zheng, D; Zoega, H | 1 |
Chung, DY; Foster, ML; McCall, KL; Moran, MT; Nichols, SD; Piper, BJ; Shah, DT; Simpson, KJ | 1 |
Brás, M; Fragoso, M; Vieira, C | 1 |
Leppert, W; Nosek, K | 1 |
Bergman, J; Paronis, CA; Spealman, RD; Withey, SL | 1 |
Desrosiers, C; Foster, ML; Herbert, J; McCall, KL; Moran, MT; Nichols, SD; Piper, BJ; Shah, DT; Simoyan, OM; Simpson, KJ | 1 |
Dart, RC; Green, JL; Olsen, H; Severtson, G; Wang, GS | 1 |
Becker, WC; Edens, EL; Frank, JW | 1 |
Dember, LM; Jhamb, M; Liebschutz, J; Roy, PJ; Weltman, M | 1 |
Cater, J; Hansen, E; Smith, T; Webster, LR | 1 |
Havig, SM; Rogde, S; Thaulow, CH; Vindenes, V; Øiestad, ÅML | 1 |
Aguilar, L; Álvarez-Navares, A; Casado-Espada, N; Gamonal-Limcaoco, S; Grau-López, L; Lozano-López, MT; Roncero, C; Vicente-Hernández, B | 1 |
Rauck, RL; Webster, L | 1 |
Qiu, S; Vasudeva, S | 1 |
DeFries, T; Leyde, S; Pratt, L; Suen, L | 1 |
Coulter, C; Garnier, M; Moore, C | 1 |
Díez-Pascual, AM; Kahrizi, M; Mirinejad, S; Mishra, S; Rahdar, A; Razlansari, M; Sargazi, S; Ulucan-Karnak, F | 1 |
Patel, KV; Sahni, S; Taylor, LF | 1 |
Johnstone, C; Koelzow, H; Moran, B; Patanwala, AE; Penm, J | 1 |
10 review(s) available for oxycodone and buprenorphine
Article | Year |
---|---|
[Driving ability under opioids: current assessment of published studies].
Topics: Accidents, Traffic; Administration, Cutaneous; Analgesics, Opioid; Automobile Driving; Buprenorphine; Fentanyl; Humans; Oxycodone; Pain; Psychomotor Performance; Reaction Time | 2008 |
[The licit opioid consumption in Denmark].
Topics: Analgesics, Opioid; Buprenorphine; Databases, Factual; Denmark; Drug Costs; Drug Utilization; Fentanyl; Humans; Neoplasms; Oxycodone; Pain; Substance-Related Disorders | 2010 |
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Hydromorphone; Long-Term Care; Morphine; Oxycodone; Oxymorphone; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Tramadol; Treatment Outcome | 2015 |
Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations.
Topics: Analgesics, Opioid; Buprenorphine; Chemistry, Pharmaceutical; Humans; Morphine; Oxycodone; Oxymorphone; Pain | 2016 |
Opioids for cancer pain - an overview of Cochrane reviews.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol | 2017 |
Opioid Rotation in Cancer Pain Treatment.
Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management | 2018 |
[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Deglutition Disorders; Fentanyl; Humans; Hydromorphone; Liver Failure; Morphine; Oxycodone; Renal Dialysis; Renal Insufficiency; Tapentadol; Tramadol | 2019 |
Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review.
Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Methadone; Morphine; Oxycodone; Psychotic Disorders; Substance Withdrawal Syndrome; Tramadol | 2021 |
Atypical opioids and their effect on respiratory drive.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Morphine; Oxycodone | 2021 |
Nanobiosensors for detection of opioids: A review of latest advancements.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Gold; Illicit Drugs; Methadone; Oxycodone; Silver; Tramadol; Wastewater | 2022 |
12 trial(s) available for oxycodone and buprenorphine
Article | Year |
---|---|
Failure of transcutaneous electrical nerve stimulation and indomethacin to reduce opiate requirement following cholecystectomy.
Topics: Buprenorphine; Cholecystectomy; Double-Blind Method; Female; Humans; Indomethacin; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Oxycodone; Pain Measurement; Pain, Postoperative; Time Factors; Transcutaneous Electric Nerve Stimulation | 1991 |
Buprenorphine as premedication and as analgesic during and after light isoflurane-N2O-O2 anaesthesia. A comparison with oxycodone plus fentanyl.
Topics: Adult; Analgesia; Anesthesia, Endotracheal; Anesthesia, General; Buprenorphine; Clinical Trials as Topic; Codeine; Female; Fentanyl; Heart Rate; Humans; Injections, Intravenous; Isoflurane; Nitrous Oxide; Oxycodone; Pain, Postoperative; Premedication; Random Allocation; Respiration | 1987 |
Use of midazolam and buprenorphine in combination anaesthesia.
Topics: Adult; Anesthesia, General; Benzodiazepines; Buprenorphine; Female; Fentanyl; Genital Diseases, Female; Humans; Midazolam; Middle Aged; Morphinans; Oxycodone; Preanesthetic Medication | 1983 |
The effect of buprenorphine and oxycodone on the intracholedochal passage pressure.
Topics: Adult; Aged; Anesthesia, Intravenous; Buprenorphine; Codeine; Common Bile Duct; Female; Humans; Male; Middle Aged; Morphinans; Oxycodone; Pressure | 1981 |
The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone.
Topics: Adult; Analgesia; Analgesics, Opioid; Buprenorphine; Double-Blind Method; Drug Synergism; Female; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Oxycodone; Pain, Intractable; Reinforcement Schedule | 2011 |
Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Chronic Pain; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Oxycodone; Transdermal Patch; Treatment Outcome | 2011 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Buprenorphine; Choice Behavior; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; In Vitro Techniques; Male; Middle Aged; Morphine; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Pain Measurement; Pupil; Reward; Self Administration; Surveys and Questionnaires; Time Factors; Token Economy; Young Adult | 2013 |
Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.
Topics: Administration, Intranasal; Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Young Adult | 2016 |
A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cancer Pain; Constipation; Delayed-Action Preparations; Drug Therapy, Combination; Fentanyl; Humans; Lactulose; Male; Middle Aged; Morphine; Oxycodone; Pain Measurement; Severity of Illness Index | 2017 |
Comparison of the Quality of Life of Cancer Patients with Pain Treated with Oral Controlled-Release Morphine and Oxycodone and Transdermal Buprenorphine and Fentanyl.
Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Delayed-Action Preparations; Female; Fentanyl; Humans; Male; Morphine; Neoplasms; Oxycodone; Quality of Life | 2019 |
A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Buprenorphine; Double-Blind Method; Female; Humans; Male; Naloxone; Oxycodone | 2020 |
49 other study(ies) available for oxycodone and buprenorphine
Article | Year |
---|---|
Sublingual absorption of selected opioid analgesics.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Analysis of Variance; Biological Availability; Buprenorphine; Fentanyl; Heroin; Humans; Hydromorphone; Levorphanol; Methadone; Morphine; Mouth; Naloxone; Oxycodone; Time Factors | 1988 |
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Topics: Aged; Ambulatory Care Facilities; Analgesics, Opioid; Buprenorphine; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization Review; Female; Fentanyl; Hospitals; Humans; Hydromorphone; Male; Middle Aged; Morphine; Oxycodone; Pain; Palliative Care; Prospective Studies; Treatment Outcome | 2005 |
Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Fentanyl; Germany; Health Services; Humans; Morphine; Oxycodone; Pain; Quality-Adjusted Life Years | 2006 |
Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.
Topics: Analgesics, Opioid; Animals; Brain; Brain Stem; Buprenorphine; Carbon Radioisotopes; Cerebellum; Competitive Bidding; Diprenorphine; Limbic System; Male; Morphine; Narcotic Antagonists; Oxycodone; Positron-Emission Tomography; Prosencephalon; Quinine; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Reproducibility of Results; Tissue Distribution | 2007 |
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Humans; Hydrocodone; Methadone; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Assessment; Risk Management; Rural Population; Suburban Population; United States; Urban Population | 2007 |
The underrecognized toll of prescription opioid abuse on young children.
Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Buprenorphine; Child, Preschool; Female; Humans; Hydrocodone; Hydromorphone; Infant; Infant, Newborn; Male; Methadone; Morphine; Oxycodone; Poisoning; Prescription Drugs; United States | 2009 |
Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
Topics: Accidental Falls; Aged; Analgesics, Opioid; Buprenorphine; Chronic Disease; Cost-Benefit Analysis; Fractures, Bone; Germany; Health Services; Humans; Markov Chains; Middle Aged; Models, Economic; Morphine; Oxycodone; Pain; Quality-Adjusted Life Years | 2009 |
Prescription of opioids in Italy: everything, but the morphine.
Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Drug and Narcotic Control; Drug Prescriptions; Fentanyl; Guideline Adherence; Humans; Italy; Morphine; Neoplasms; Oxycodone; Pain; Practice Guidelines as Topic; Practice Patterns, Physicians'; Time Factors | 2009 |
Cross-reactivity of naloxone with oxycodone immunoassays: implications for individuals taking Suboxone.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross Reactions; Drug Combinations; Humans; Immunoenzyme Techniques; Naloxone; Oxycodone; Patient Compliance | 2009 |
Case histories in pharmaceutical risk management.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Dextroamphetamine; Drug and Narcotic Control; Drug Industry; History, 20th Century; History, 21st Century; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Naloxone; Oxycodone; Product Surveillance, Postmarketing; Risk Management; Sodium Oxybate; Substance-Related Disorders | 2009 |
Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Buprenorphine; Chromatography, Liquid; Cocaine; Codeine; Dronabinol; Ethylmorphine; Humans; Illicit Drugs; Methadone; Morphine; Oxycodone; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2011 |
Is maternal opioid use hazardous to breast-fed infants?
Topics: Age Factors; Analgesics, Opioid; Breast Feeding; Buprenorphine; Codeine; Female; Humans; Hydrocodone; Infant; Infant, Newborn; Meperidine; Methadone; Milk, Human; Morphine; Oxycodone | 2012 |
The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
Topics: Analgesics, Opioid; Buprenorphine; Drug and Narcotic Control; Drug Approval; Health Services Accessibility; Healthcare Disparities; Humans; Legislation, Drug; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Pain; Prescription Drugs; Substance-Related Disorders; United States; United States Food and Drug Administration | 2012 |
Comparison of fatal poisonings by prescription opioids.
Topics: Accidents; Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Codeine; Dextropropoxyphene; Drug Overdose; Ethanol; Fentanyl; Finland; Forensic Toxicology; Humans; Hypnotics and Sedatives; Methadone; Morphine; Opioid-Related Disorders; Oxycodone; Poisoning; Prescription Drug Misuse; Suicide; Tramadol; Young Adult | 2012 |
False-positive buprenorphine EIA urine toxicology results due to high dose morphine: a case report.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Enzyme Assays; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Humans; Low Back Pain; Male; Middle Aged; Morphine; Oxycodone; Reagent Kits, Diagnostic | 2012 |
Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Indians, North American; Male; Naloxone; Narcotic Antagonists; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Prescription Drug Misuse | 2013 |
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Statistics, Nonparametric | 2013 |
In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
Topics: Analgesics, Opioid; Animals; Benzeneacetamides; Buprenorphine; Castor Oil; Constipation; Diarrhea; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Hot Temperature; Male; Morphine; Morphine Derivatives; Oxycodone; Pain; Pyrrolidines; Rats, Sprague-Dawley; Respiratory Insufficiency | 2015 |
A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function.
Topics: Adaptive Immunity; Adult; Analgesics, Opioid; Buprenorphine; Codeine; Fentanyl; Humans; Immunity, Innate; Interleukin-2; Interleukin-6; Leukocytes, Mononuclear; Methadone; Monocytes; Morphine; Neutrophils; Oxycodone; Phagocytosis; Respiratory Burst; Tramadol | 2014 |
Changes in trends and pattern of strong opioid prescribing in primary care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain; Practice Patterns, Physicians'; Primary Health Care; United Kingdom; Young Adult | 2014 |
Compulsive-like responding for opioid analgesics in rats with extended access.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug-Seeking Behavior; Fentanyl; Heroin; Male; Opioid-Related Disorders; Oxycodone; Rats, Wistar; Self Administration; Time Factors | 2015 |
Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Injections, Intraventricular; Male; Methadone; Microinjections; Oxycodone; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2014 |
Increasing use of opioids for pain.
Topics: Analgesics, Opioid; Buprenorphine; Drug Prescriptions; Female; Fentanyl; Humans; Male; Morphine; Oxycodone; Pain; Practice Patterns, Physicians'; Primary Health Care | 2014 |
Injection of crushed tablets--a prospective observational study.
Topics: Adolescent; Adult; Azabicyclo Compounds; Benzodiazepines; Buprenorphine; C-Reactive Protein; Female; gamma-Aminobutyric Acid; Humans; Injections, Intravenous; Male; Methylphenidate; Morphine; Oxycodone; Piperazines; Poison Control Centers; Pregabalin; Prospective Studies; Substance-Related Disorders; Sweden; Tablets; Young Adult | 2014 |
Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
Topics: Administration, Oral; Analgesics, Opioid; Antifungal Agents; Azoles; Biotransformation; Buprenorphine; Chromatography, Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Kinetics; Liver; Methadone; Microsomes, Liver; Models, Biological; Molecular Structure; Oxycodone; Recombinant Proteins; Risk Assessment; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Substrate Specificity; Tandem Mass Spectrometry | 2015 |
Effectiveness of opioid analgesics in chronic noncancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome | 2015 |
Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Morphine Dependence; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Retrospective Studies | 2017 |
New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Chronic Pain; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Utilization; Female; Fentanyl; Homes for the Aged; Humans; Long-Term Care; Male; Morphine; Nursing Homes; Oxycodone; Oxymorphone; Practice Patterns, Physicians'; Rhode Island; Tramadol | 2016 |
Definitive Drug and Metabolite Screening in Urine by UPLC-MS-MS Using a Novel Calibration Technique.
Topics: Amphetamine; Benzodiazepines; Buprenorphine; Calibration; Chromatography, High Pressure Liquid; Cocaine; Humans; Limit of Detection; N-Methyl-3,4-methylenedioxyamphetamine; Opiate Alkaloids; Oxycodone; Phencyclidine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.
Topics: Adult; Benzodiazepines; Buprenorphine; Cocaine; Community Health Services; Counseling; Drug Therapy, Combination; Female; Humans; Indians, North American; Male; Medication Adherence; Middle Aged; Morphine; Naloxone; Narcotic Antagonists; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Program Evaluation; Retrospective Studies; Rural Health Services; Substance Abuse Detection; Suicide; Young Adult | 2017 |
In contrast to morphine, buprenorphine enhances macrophage-induced humoral immunity and, as oxycodone, slightly suppresses the effector phase of cell-mediated immune response in mice.
Topics: Animals; Buprenorphine; Cells, Cultured; Cytokines; Dermatitis, Contact; Homeostasis; Humans; Immunity, Cellular; Immunity, Humoral; Immunomodulation; Macrophages; Male; Mice; Mice, Inbred CBA; Morphine; Nitric Oxide; Oxycodone; Reactive Oxygen Species | 2018 |
Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Crime; Databases, Factual; Education; Employment; England; Health Status; Housing; Humans; Income; Methadone; Morphine; Oxycodone; Practice Patterns, Physicians'; Primary Health Care; Residence Characteristics; Retrospective Studies; Socioeconomic Factors; Tramadol | 2018 |
Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; In Vitro Techniques; Inhibitory Concentration 50; Insecta; Male; Methadone; Microsomes, Liver; Neuromuscular Agents; Oxycodone | 2018 |
Opioid Deaths in Milwaukee County, Wisconsin 2013-2017: The Primacy of Heroin and Fentanyl.
Topics: Analgesics, Opioid; Buprenorphine; Coroners and Medical Examiners; Fentanyl; Heroin; Humans; Hydrocodone; Illicit Drugs; Incidence; Methadone; Opioid-Related Disorders; Oxycodone; Substance-Related Disorders; Wisconsin | 2019 |
Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
Topics: Buprenorphine; Cannabinoids; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Illicit Drugs; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Oxymorphone; Retrospective Studies; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry | 2018 |
Case 6-2019: A 29-Year-Old Woman with Nausea, Vomiting, and Diarrhea.
Topics: Acetaminophen; Adult; Buprenorphine; Cocaine-Related Disorders; Diagnosis, Differential; Diarrhea; Drug Combinations; Female; Humans; Illicit Drugs; Naloxone; Narcotic Antagonists; Nausea; Opioid-Related Disorders; Oxycodone; Substance Abuse Detection; Vomiting | 2019 |
Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Australia; Buprenorphine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Opioid Epidemic; Opioid-Related Disorders; Oxycodone; Pain; Policy Making; Practice Patterns, Physicians'; Sex Factors; Transdermal Patch; Young Adult | 2019 |
Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cocaine; Crime; Drug Overdose; Drug Users; Female; Fentanyl; Humans; Hydrocodone; Hypnotics and Sedatives; Law Enforcement; Maine; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Sex Distribution; Young Adult | 2019 |
Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Buprenorphine; Dose-Response Relationship, Drug; Drug Partial Agonism; Male; Morphine; Oxycodone; Pain Measurement; Receptors, Opioid, mu; Saimiri; Self Administration | 2019 |
Increasing heroin, cocaine, and buprenorphine arrests reported to the Maine Diversion Alert Program.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Buprenorphine; Cocaine; Drug Users; Female; Fentanyl; Harm Reduction; Heroin; Humans; Hydrocodone; Hypnotics and Sedatives; Maine; Male; Middle Aged; Narcotic-Related Disorders; Oxycodone; Public Health; Sex Distribution; Substance-Related Disorders; Young Adult | 2019 |
The impact of the prescription opioid epidemic on young children: Trends and mortality.
Topics: Analgesics, Opioid; Buprenorphine; Child, Preschool; Epidemics; Female; Fentanyl; Humans; Infant; Male; Methadone; Morphine; Opioid Epidemic; Oxycodone; Poison Control Centers; Prescription Drugs | 2020 |
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Humans; Low Back Pain; Male; Middle Aged; Oxycodone | 2020 |
Pain management in patients with chronic kidney disease and end-stage kidney disease.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Hydromorphone; Kidney Failure, Chronic; Oxycodone; Pain; Pain Management; Receptors, Opioid, mu; Renal Insufficiency, Chronic | 2020 |
Methadone, Buprenorphine, Oxycodone, Fentanyl and Tramadol in Multiple Postmortem Matrices.
Topics: Analgesics, Opioid; Autopsy; Buprenorphine; Fentanyl; Methadone; Oxycodone; Tramadol | 2022 |
A case report of satisfactory post-left knee replacement pain control after switching from oxycodone to buprenorphine.
Topics: Analgesics, Opioid; Arthroplasty, Replacement, Knee; Buprenorphine; Humans; Male; Oxycodone; Pain | 2021 |
Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report.
Topics: Analgesics, Opioid; Anemia, Sickle Cell; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Young Adult | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
Topics: Acetaminophen; Analgesics, Opioid; Animals; Breakthrough Pain; Buprenorphine; Cattle; Chronic Pain; Female; Humans; Oxycodone; Quality of Life | 2023 |
Effectiveness of Sublingual Buprenorphine for Pain Control in the ICU.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Humans; Male; Middle Aged; Oxycodone; Pain; Retrospective Studies | 2023 |